Our ambition

Pave the way for a truly personalized approach in cancer.

READ MORE

Translational biomarker approaches
to address patient needs

Pharmaco-imaging in support of therapeutic development

and for drug targeting.

READ MORE

State-of-the-art models for optimal
predictive value

Patient-derived xenografts and human immune system

models to allow better decisions.

READ MORE

Next generation kinase inhibitors
with unique properties

Potent and selective Nanocyclix leads for known

and novel kinases.

.

READ MORE

We partner to advance cancer
research

Joining forces to the benefits of patients.